Petco Health and Wellness Company, Inc.

DB:7G9 Stock Report

Market Cap: €1.2b

Petco Health and Wellness Company Valuation

Is 7G9 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7G9 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7G9 (€4.18) is trading below our estimate of fair value (€5.37)

Significantly Below Fair Value: 7G9 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7G9?

Other financial metrics that can be useful for relative valuation.

7G9 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.7x
Enterprise Value/EBITDA22.9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does 7G9's PS Ratio compare to its peers?

The above table shows the PS ratio for 7G9 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
DOU Douglas
0.5x6.2%€2.0b
FIE Fielmann Group
1.6x6.7%€3.5b
MRX Mister Spex
0.3x2.2%€68.2m
BIKE Bike24 Holding
0.3x6.5%€60.9m
7G9 Petco Health and Wellness Company
0.2x1.4%€1.3b

Price-To-Sales vs Peers: 7G9 is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.7x).

Price to Earnings Ratio vs Industry

How does 7G9's PE Ratio compare vs other companies in the DE Specialty Retail Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a35.0%
 n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a35.0%
 n/an/an/a
No more companies

Price-To-Sales vs Industry: 7G9 is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Specialty Retail industry average (0.4x).

Price to Sales Ratio vs Fair Ratio

What is 7G9's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7G9 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.3x

Price-To-Sales vs Fair Ratio: 7G9 is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7G9 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.18
€3.46
-17.3%
31.9%€5.09€1.39n/a12
Nov ’25€3.89
€3.46
-11.1%
31.9%€5.09€1.39n/a12
Oct ’25€3.95
€3.09
-21.8%
29.0%€4.48€1.34n/a12
Sep ’25€2.74
€2.95
+7.6%
35.8%€4.60€0.92n/a12
Aug ’25€2.82
€2.95
+4.6%
35.8%€4.60€0.92n/a12
Jul ’25€3.05
€2.79
-8.2%
33.4%€4.59€0.92n/a12
Jun ’25€3.48
€2.73
-21.5%
32.9%€4.61€0.92n/a12
May ’25€1.39
€2.78
+100.0%
45.4%€5.57€0.93n/a14
Apr ’25€2.06
€3.00
+45.4%
42.6%€5.54€0.92n/a14
Mar ’25€2.36
€3.48
+47.7%
32.3%€5.59€0.93n/a14
Feb ’25€2.24
€3.44
+53.4%
32.3%€5.51€0.92n/a14
Jan ’25€2.88
€3.61
+25.2%
24.3%€5.50€2.52n/a14
Dec ’24€3.12
€3.85
+23.6%
30.6%€6.44€2.53n/a13
Nov ’24€3.06
€6.07
+98.3%
25.3%€9.45€3.78€3.8913
Oct ’24€3.80
€6.19
+62.9%
22.4%€9.36€3.74€3.9513
Sep ’24€4.72
€6.12
+29.7%
22.4%€9.26€3.70€2.7413
Aug ’24€7.20
€9.09
+26.3%
17.3%€11.04€5.52€2.8213
Jul ’24€8.05
€9.09
+13.0%
17.3%€11.04€5.52€3.0513
Jun ’24€6.85
€9.16
+33.7%
17.0%€11.19€5.59€3.4814
May ’24€8.95
€9.69
+8.3%
19.9%€13.61€6.35€1.3914
Apr ’24€8.20
€10.25
+25.0%
28.3%€18.44€6.45€2.0613
Mar ’24€9.55
€13.19
+38.1%
20.7%€18.64€8.39€2.3613
Feb ’24€10.90
€12.98
+19.1%
20.9%€18.44€8.30€2.2413
Jan ’24€8.75
€13.63
+55.8%
20.4%€18.86€8.49€2.8813
Dec ’23€10.50
€14.10
+34.3%
23.2%€20.90€8.55€3.1213
Nov ’23n/a
€17.60
0%
27.5%€30.37€10.12€3.0613

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y